Gut microbiota as a biomarker and modulator of anti-tumor immunotherapy outcomes.

MLA

Yan, Jiexi, et al. “Gut Microbiota as a Biomarker and Modulator of Anti-Tumor Immunotherapy Outcomes.” Frontiers in Immunology, Dec. 2024, pp. 1–23. EBSCOhost, https://doi.org/10.3389/fimmu.2024.1471273.

APA

Yan, J., Yang, L., Ren, Q., Zhu, C., Du, H., Wang, Z., Qi, Y., Xian, X., & Chen, D. (2024). Gut microbiota as a biomarker and modulator of anti-tumor immunotherapy outcomes. Frontiers in Immunology, 1–23. https://doi.org/10.3389/fimmu.2024.1471273

Chicago

Yan, Jiexi, Lu Yang, Qingmiao Ren, Chan Zhu, Haiyun Du, Zhouyu Wang, Yaya Qi, Xiaohong Xian, and Dongsheng Chen. 2024. “Gut Microbiota as a Biomarker and Modulator of Anti-Tumor Immunotherapy Outcomes.” Frontiers in Immunology, December, 1–23. doi:10.3389/fimmu.2024.1471273.